Therapy Areas: Autoimmune
24 November 2021 - - US-based pharmaceutical company Merck (NYSE: MRK) has posted an update regarding the Phase 2 IMAGINE-DR clinical trial (MK-8507-13), which is evaluating the investigational combin...
23 November 2021 - - US-based IVD manufacturer Applied BioCode has released 28 Fungal Analyte Specific Reagents (ASRs) for use in molecular tests. (15 ASRs for mold pathogens, 10 ASRs for ye...
22 November 2021 - - The first of 100 subjects were dosed in an open-label bridging study of AKS-452, US-based biologic therapeutics developer Akston Biosciences Corp's protein subunit COVID-19 v...
19 November 2021 - - New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials both showed robust efficacy from a one-time intramuscular dose of the long-a...
17 November 2021 - - US-based pharmaceutical company MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) has received US Food and Drug Administration clearance of its Investigational New Drug application f...
16 November 2021 - - US-based synthetic DNA company Twist Bioscience Corp. (NASDAQ: TWST) has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop an...
Related Headlines